{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1397","meta":{"versionId":"9","lastUpdated":"2018-03-10T01:00:08.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2018-03-10"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1397","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1397"}],"version":"20180310","name":"EstradiolNorgestimateBiphasic","title":"Estradiol / Norgestimate Biphasic","status":"active","experimental":false,"date":"2018-03-10T01:00:08-05:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"749850","display":"{15 (Estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (Estradiol 1 MG Oral Tablet) } Pack"}]}]},"expansion":{"identifier":"urn:uuid:229020a7-0da3-457b-a133-37f9151de4eb","timestamp":"2023-12-11T02:32:38-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"749850","display":"{15 (estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (estradiol 1 MG Oral Tablet) } Pack"}]}}